Back

effectiveness and safety of reduced dose of direct oral anticoagulants in real world practice in asia

18 March 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Atrial Fibrillation - Stroke Prevention Oral Anticoagulation EHRA Premium Access EHRA 2019

About the speaker

Photo
Assistant Professor Kwang-No Lee

Ajou University, Suwon (Korea (Republic of))

9 More presentations in this session

Presentation thumbnail
Mr J. Ramos Maqueda (Zaragoza, ES)
Abstract
Presentation thumbnail
Doctor A. Adukauskaite (Innsbruck, AT)
Abstract
Presentation thumbnail
Ms F. Liljegren (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Doctor I. Pupkevica (Riga, LV)
Abstract
Presentation thumbnail
Ms K. Grinberga (Riga, LV)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Atrial Fibrillation - Stroke Prevention

The Event

Event poster

EHRA 2019

18 March 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of baseline characteristics and outcomes of on-label full dose (20mg) and off-label reduced dose (15mg) rivaroxaban in patients with atrial fibrillation in Asian elderly patients
25 August 2023
thumbnail
Congress Presentation
The prevalence and safety of direct oral anticoagulants in patients with non-atrial fibrillation associated intra-cardiac thrombus
27 August 2021
thumbnail
Congress Presentation
Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence
27 August 2022
thumbnail
Congress Presentation
Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources